SpringWorks Therapeutics reports the pricing of its initial public offering of 9,000,000 shares of its common stock at a price to the public of $18.00 per share. The gross proceeds to SpringWorks from the offering, before deducting underwriting discounts and commissions and estimated offering expenses to be payable by SpringWorks, are expected to be $162 million.
The shares are expected to begin trading on the Nasdaq Global Select Market on September 13, 2019, under the ticker symbol “SWTX” and the offering is expected to close on September 17, 2019, subject to the satisfaction of customary closing conditions. more